(Q34708014)

4 August 2017

1 reference

title

Preferential targeting of apoptosis in tumor versus normal cells (English)

1 reference

4 August 2017

author name string

Barbara A Woynarowska

series ordinal

1

1 reference

4 August 2017

Jan M Woynarowski

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Biochimica et Biophysica Acta

4 August 2017

published in

1 reference

4 August 2017

volume

1587

1 reference

4 August 2017

issue

2-3

1 reference

4 August 2017

page(s)

309-317

1 reference

Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Dysregulation of apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

1 reference

7 January 2021

Induction of apoptosis by cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

1 reference

7 January 2021

Signalling apoptosis: a radical approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Triggering and modulation of apoptosis by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Redox regulation of cellular signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Mitochondria as the central control point of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Mitochondria as regulators of apoptosis: doubt no more.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Oxidative stress induces caspase-independent retinal apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Oxidative stress and adenine nucleotide control of mitochondrial permeability transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Properties and biological activities of thioredoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Redox regulation of cellular activation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Physiological functions of thioredoxin and thioredoxin reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Cellular thiols and redox-regulated signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Gene expression and the thiol redox state

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Thiols can either enhance or suppress DNA damage induction by catecholestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Thioredoxin reductase as a pathophysiological factor and drug target

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Nuclear and mitochondrial apoptotic pathways of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Oxidative stress and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Apoptotic DNA fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Apoptosis and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Thiol-oxidizing agent diamide and acidic pH enhance lipid peroxidation of rat heart mitochondria and cardiolipin-cytochrome c complex

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Thiol-mediated apoptosis in prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Prooxidants open both the mitochondrial permeability transition pore and a low-conductance channel in the inner mitochondrial membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Thiols in cellular redox signalling and control

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Transcriptional responses to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Preclinical evaluation of illudins as anticancer agents: basis for selective cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

A phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

A randomized Phase II trial in patients with carcinoma of an unknown primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Phase I study of irofulven (MGI 114), an acylfulvene illudin analog, in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114)

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF)

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

MGI 114: augmentation of antitumor activity when combined with topotecan.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Efficacy of MGI 114 (HMAF) against the MRP+ metastatic MV522 lung carcinoma xenograft.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

The Number of Platinum Atoms Binding to DNA, RNA and Protein Molecules of HeLa Cells Treated with Cisplatin at Its Mean Lethal Concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Binding characteristics of (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-2-platin um(II) to DNA, RNA and protein molecules in HeLa cells and its lethal effect: comparison with cis- and trans-diamminedichloroplatinums(II).

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Effects of bizelesin (U-77,779), a bifunctional alkylating minor groove binder, on replication of genomic and simian virus 40 DNA in BSC-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

Reducing environment protects sinusoidal lymphocytes isolated from normal human liver from apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2802%2900094-7

7 January 2021

10.1016/S0925-4439(02)00094-7

Identifiers

DOI

1 reference

4 August 2017

1 reference